When "Brain Fog" Isn't Just Stress: Cognitive Changes in the Menopause Transition

By Hanah Polotsky, MD | Board-Certified Endocrinologist | OpExMD

The story is startlingly common, yet often dismissed. She sat with her notes, professional and composed, describing a cognitive system that was failing her. 

"I forget words mid-sentence." 

"I walk into a room and don't remember why." 

"I read the same paragraph three times." 

She then shared the all-too-familiar punchline: "My doctor told me my labs are normal and I should reduce my stress."

This pattern of forgetfulness, difficulty concentrating, mental slowness, and the sense that thinking requires immense effort is something I often hear from patients, friends, and colleagues. What's rare is for someone to take this experience seriously enough to seek a root cause. The explanation, in many cases, lies in the menopausal transition.

The Misleading Nature of "Normal"

"Brain fog" is not a diagnosis; it is the patient's term for a significant change in cognitive function. While it is linked to various conditions outside of perimenopause, thyroid dysfunction, long COVID, autoimmune and inflammatory disease, sleep disorders, and so much more, the menopausal pattern is distinct and consistent. Women often notice that word retrieval is less automatic, working memory is unreliable, and processing speed has slowed, increasing the effort required for mental work.

Here is a critical point: most women with this pattern score within normal limits on formal cognitive testing. This is because "normal" is not the same as "baseline". If a high-functioning woman’s baseline was high, a shift that is still within the "normal" range on a standardized test is a decrement she feels profoundly every single day. The tests currently in routine clinical use were simply not designed to detect the subtle yet professionally significant shifts that high-functioning women first notice in themselves.

Estrogen, the Brain's Co-Pilot

Estrogen is active throughout the central nervous system, particularly in regions that govern memory consolidation and executive function. During perimenopause, estradiol fluctuates; it doesn't just decline, which destabilizes the systems supporting cognitive efficiency. Rigorous research, including a 2022 International Menopause Society white paper and a 2026 systematic review, documents measurable changes, with verbal learning, verbal memory, and processing speed being the most consistently affected domains. Working memory and attention follow.

While effect sizes are often described as "modest" at the population level, they can be significant for an individual whose career demands operating at the high end of her cognitive range. The cognitive profiles are heterogeneous, meaning the experience is not identical for every woman, which further highlights the inadequacy of the blanket reassurance, "your labs are normal."

The Interwoven Role of Sleep and Vasomotor Symptoms

Sleep is often the first domino to fall. Waking at 3 or 4 AM, not restless, just awake, is common. Hormonal fluctuations disrupt the architecture of sleep, the stages vital for memory consolidation, emotional regulation, and decision-making. Robust evidence confirms that this sleep disruption affects verbal learning and creates memory difficulties in menopausal women.

Furthermore, vasomotor symptoms (hot flashes and night sweats) play a hidden role. Women often minimize mild hot flashes, but physiologic monitoring shows that objectively measured vasomotor symptoms, especially those occurring during sleep, are associated with poorer verbal memory performance, even independent of subjective sleep complaints. Research has found that vasomotor symptoms and sleep disturbances roughly double each other's odds, forming a powerful, self-reinforcing cluster.

Ruling Out Other Explanations

A thoughtful menopause clinician resists the reflex to attribute every midlife cognitive complaint to perimenopause or, on opposite, to dismiss it. The differential diagnosis matters. Other treatable conditions can mimic perimenopausal brain fog, and they often coexist:

• Hypothyroidism

• Sleep Apnea (common with midlife weight gain or visceral fat increase)

• Iron or B12 Deficiency

• Untreated Depression or Anxiety

• Medication Burden (e.g., anticholinergics, benzodiazepines)

• Post-viral Cognitive Dysfunction (e.g., following COVID)

Two things can be true at once. The presence of menopausal symptoms does not rule out any of these other contributors.

Addressing the Elephant in the Room: Is This Early Dementia?

For the vast majority of women, no. The cognitive changes of perimenopause are transient and do not, in isolation, predict dementia. For many, cognitive function stabilizes or improves after the transition. This is a crucial point that must be communicated clearly.

However, midlife is a critical window for long-term brain health. Addressing sleep quality, cardiometabolic health, vascular risk, and severe vasomotor symptoms now aligns with the evidence for maintaining cognitive trajectory over time. It is important to note that claiming any single intervention, including hormone therapy, prevents Alzheimer's disease is not currently supported by the evidence.

A Comprehensive Clinical Approach

My approach is not to hunt for an abnormal lab value, as one is usually not present. Instead, I build a complete picture by looking at:

• Symptom Pattern: When do symptoms appear? What type of thinking is affected?

• Sleep: Quantitative and qualitative assessment of sleep architecture.

• Physiology: Are vasomotor symptoms present physiologically, even if mildly reported?

• Underlying Contributors: Thorough screening for thyroid, B12, iron, sleep-disordered breathing, and mood disorders.

• Life Context (The Stress Factor): Assessing caregiving burden, work demands, and role overcommitment. Psychosocial stress is not a "soft variable;" it is an independent predictor of brain fog severity.

From this picture, we develop a personalized plan. Sometimes the primary driver is sleep. Sometimes hormone therapy is the appropriate conversation, not for cognition in isolation, but because the timing of initiation and route of administration matter profoundly. Exercise is also strongly supported as a way to improve processing speed and executive function. The answer is rarely one thing.

The transition itself is not pathological, but the clinical reflex to dismiss it, to hand a high-functioning woman a normal lab result and send her home to "manage her stress" has real consequences. 

She leaves without a valid explanation for something she lives with every day.

She deserves better than that.

The Physician's Guide to The Midlife Brain

This is my gift to help you on your journey. Get your copy now.

Dr. Hanah Polotsky is a board-certified endocrinologist and founder of OpExMD, a concierge clinical practice focused on menopause, metabolism, and midlife health optimization for high-performing women. Based in Colorado. Telemedicine consultations for women who live in CO, NY, and NJ at opexmd.com.

---

References

Bangle, A., Williams, D., Walters, J., & Nguyen, L. (2025). Cognitive functioning in perimenopause: An updated systematic review and meta-analysis. Psychology and Aging. Advance online publication. https://doi.org/10.1037/pag0000946

Barth, C., Crestol, A., de Lange, A. G., & Galea, L. A. M. (2023). Sex steroids and the female brain across the lifespan: Insights into risk of depression and Alzheimer's disease. The Lancet Diabetes & Endocrinology, 11(12), 926–941. https://doi.org/10.1016/S2213-8587(23)00224-3

Bofill Rodriguez, M., Yong, L. N., Mirkov, S., Bekos, C., Lethaby, A., & Farquhar, C. (2025). Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews, 11, CD004143. https://doi.org/10.1002/14651858.CD004143.pub6

Denno, P., Zhao, S., Husain, M., & Hampshire, A. (2025). Defining brain fog across medical conditions. Trends in Neurosciences, 48(5), 330–348. https://doi.org/10.1016/j.tins.2025.01.003

Drogos, L. L., Rubin, L. H., Geller, S. E., Banuvar, S., Shulman, L. P., & Maki, P. M. (2013). Objective cognitive performance is related to subjective memory complaints in midlife women with moderate to severe vasomotor symptoms. Menopause, 20(12), 1236–1242. https://doi.org/10.1097/GME.0b013e318291f5a6

Epperson, C. N., Sammel, M. D., & Freeman, E. W. (2013). Menopause effects on verbal memory: Findings from a longitudinal community cohort. Journal of Clinical Endocrinology & Metabolism, 98(9), 3829–3838. https://doi.org/10.1210/jc.2013-1808

Fogel, J., Rubin, L. H., Kilic, E., Walega, D. R., & Maki, P. M. (2020). Physiologic vasomotor symptoms are associated with verbal memory dysfunction in breast cancer survivors. Menopause, 27(11), 1209–1219. https://doi.org/10.1097/GME.0000000000001608

Furey, R. T., Thomas, E. H. X., Kulkarni, J., & Gurvich, C. (2025). Subjective versus objective cognition during menopause: A systematic review and meta-analysis. Journal of the International Neuropsychological Society, 31(5-6), 459–477. https://doi.org/10.1017/S1355617725101306

Khadilkar, S., Mahajan Bhanushali, J., Mahto, A. P., & Khadilkar, S. (2026). Cognition in menopausal women. International Journal of Gynecology & Obstetrics. Advance online publication. https://doi.org/10.1002/ijgo.70944

Maki, P. M., & Jaff, N. G. (2022). Brain fog in menopause: A health-care professional's guide for decision-making and counseling on cognition. Climacteric, 25(6), 570–578. https://doi.org/10.1080/13697137.2022.2122792

Maki, P. M., Inan Eroglu, E., Janssenswillen, C., Dinkel-Keuthage, C., et al. (2026). Associations between vasomotor symptoms, sleep disturbances, and frequent mood changes individually and within symptom groups across the menopausal transition and early postmenopause: Observations from the Study of Women's Health Across the Nation. Menopause. Advance online publication.

McWhirter, L., Smyth, H., Hoeritzauer, I., Couturier, A., Stone, J., & Carson, A. J. (2023). What is brain fog? Journal of Neurology, Neurosurgery, and Psychiatry, 94(4), 321–325. https://doi.org/10.1136/jnnp-2022-329683

Mosconi, L., Berti, V., Quinn, C., McHugh, P., Petrongolo, G., Osorio, R. S., Connaughty, C., Pupi, A., Vallabhajosula, S., Isaacson, R. S., de Leon, M. J., Swerdlow, R. H., & Brinton, R. D. (2017). Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery. PLoS One, 12(10), e0185926. https://doi.org/10.1371/journal.pone.0185926

Pankowski, D., & Wytrychiewicz-Pankowska, K. (2025). Prevalence, hormonal correlates, severity, and neural basis of neurocognitive impairment in patients with hypothyroidism: Systematic review and meta-analyses. Alzheimer's & Dementia, 21(11), e70924. https://doi.org/10.1002/alz.70924

Puri, T. A., Gravelsins, L. L., Alexander, M. W., McGovern, A. J., Duarte Guterman, P., Rabin, J. S., Murphy, K. J., & Galea, L. A. M. (2025). Association between menopause age and estradiol-based hormone therapy with cognitive performance in cognitively normal women in the CLSA. Neurology, 105(6), e213995. https://doi.org/10.1212/WNL.0000000000213995

Samudra, N., et al. (2026). Menopause, cognition, and Alzheimer's disease risk. Current Opinion in Obstetrics and Gynecology, 38(2), 131–138. https://doi.org/10.1097/GCO.0000000000001087

Samuels, M. H., & Bernstein, L. J. (2022). Brain fog in hypothyroidism: What is it, how is it measured, and what can be done about it. Thyroid, 32(7), 752–763. https://doi.org/10.1089/thy.2022.0139

Williams, M., & Maki, P. M. (2025). A review of cognitive, sleep, and mood changes in the menopausal transition: Beyond vasomotor symptoms. Obstetrics & Gynecology, 146(3), 350–359. https://doi.org/10.1097/AOG.0000000000005914